Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

How Doctors Judge Whether a Medical Study Can Be Trusted

1The Clinical Question and Why Study Design Follows From It2Randomization, Allocation, and the Logic of Comparison3Blinding, Follow-Up, and Who Actually Got Analyzed4Reading the Result: Effect Size, Uncertainty, and Significance5Applicability: Does This Result Fit My Patient?6Combining Studies and Forming a Verdict
Combining Studies and Forming a Verdict

Detecting Heterogeneity and Publication Bias

2 / 4
Start with the forest plot on the left. Each horizontal line is one trial's estimate, and the spread of those lines tells you how much the trials disagree. When you increase the true effect variation slider, watch the lines fan out — that is heterogeneity, and the I-squared value rises with it. Now look at the funnel plot on the right. Each point is a study, plotted by its effect against its precision. With no bias, the points should form a symmetric inverted funnel. Now toggle the omission of small null studies. See the funnel lose its symmetry on one side? That asymmetry is the signature of publication bias — the missing studies are the ones that found nothing. Rotate the view and select individual studies to see how each one sits in both plots at once. The lesson is that both heterogeneity and publication bias are properties of the whole collection, and both require you to interpret, not just read a number.
0:00 / 0:00

Two problems can undermine a pooled result even when the studies were similar enough to combine. The first is heterogeneity: the trial results disagree with each other by more than chance would explain. Statistical tests such as Cochran's Q and the I-squared statistic quantify this. I-squared is often read as the percentage of variability across trials that is due to real differences rather than sampling error; values above roughly 50 percent are commonly treated as substantial. Heterogeneity is not automatically fatal, but it changes what the summary means: a pooled estimate from highly heterogeneous trials is an average across effects that may differ, and the reasons for the disagreement — different doses, different populations, different outcome definitions — usually matter more than the average itself.

The second problem is publication bias. Studies with positive or statistically significant results are more likely to be published, and more likely to be published quickly, than studies with null results. If a review captures only the published literature, the pooled estimate can be shifted in the favorable direction. A funnel plot is a common visual check: it plots each study's effect against a measure of its precision, and in the absence of bias the points should form a roughly symmetric inverted funnel. Asymmetry — especially missing studies in the region where small null studies would fall — is a signal that publication bias may be present. Funnel-plot inspection is a judgment, not a definitive test, and it is unreliable when fewer than about ten studies are included.

References

  1. [1]Cochrane Handbook, Chapter 10, Section 10.10: Heterogeneitytraining.cochrane.org
  2. [2]Cochrane Handbook, Chapter 13: Assessing risk of bias due to missing results in a synthesistraining.cochrane.org
Previous2 / 4Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion